UK Viral Inactivation Market Size & Outlook, 2025-2030

The viral inactivation market in UK is expected to reach a projected revenue of US$ 102.2 million by 2030. A compound annual growth rate of 13.3% is expected of UK viral inactivation market from 2025 to 2030.
Revenue, 2024 (US$M)
$48.7
Forecast, 2030 (US$M)
$102.2
CAGR, 2025 - 2030
13.3%
Report Coverage
UK

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK viral inactivation market, 2018-2030 (US$M)

UK viral inactivation market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK viral inactivation market highlights

  • The UK viral inactivation market generated a revenue of USD 48.7 million in 2024 and is expected to reach USD 102.2 million by 2030.
  • The UK market is expected to grow at a CAGR of 13.3% from 2025 to 2030.
  • In terms of segment, kits and reagents was the largest revenue generating product & service in 2024.
  • Services is the most lucrative product & service segment registering the fastest growth during the forecast period.


Viral inactivation market data book summary

Market revenue in 2024USD 48.7 million
Market revenue in 2030USD 102.2 million
Growth rate13.3% (CAGR from 2025 to 2030)
Largest segmentKits and reagents
Fastest growing segmentServices
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits and reagents, Systems & Accessories, Services


Other key industry trends

  • In terms of revenue, UK accounted for 6.8% of the global viral inactivation market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany viral inactivation market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 110.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Inactivation Market Companies

Name Profile # Employees HQ Website
Vironova AB View profile 101-250 Stockholm, Stockholms Lan, Sweden, Europe https://www.vironova.com/
Texcell SA View profile 11-50 Frederick, Maryland, United States, North America http://www.texcell.com/
Rad Source Technologies View profile 11-50 Suwanee, Georgia, United States, North America http://www.radsource.com/
Mettler Toledo View profile 10001+ Columbus, Ohio, United States, North America http://www.mt.com
Cytiva View profile 10001+ Marlborough, Massachusetts, United States, North America https://www.cytivalifesciences.com/en/us
Parker Hannifin Corp View profile 62730 6035 Parkland Boulevard, Cleveland, OH, United States, 44124-4141 http://www.phstock.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Sartorius AG View profile 14338 Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 https://www.sartorius.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

UK viral inactivation market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral inactivation market will help companies and investors design strategic landscapes.


Kits and reagents was the largest segment with a revenue share of 63.86% in 2024. Horizon Databook has segmented the UK viral inactivation market based on kits and reagents, systems & accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.


The viral inactivation market in the UK held a significant share in 2024 due to a strong biopharmaceutical sector and advanced research infrastructure. Demand is fueled by vaccine production, biologics development, and stringent regulatory standards. Companies focus on innovative solutions and partnerships to enhance manufacturing efficiency, ensuring compliance and competitiveness in the global market.

Reasons to subscribe to UK viral inactivation market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK viral inactivation market databook

  • Our clientele includes a mix of viral inactivation market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK viral inactivation market , including forecasts for subscribers. This country databook contains high-level insights into UK viral inactivation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK viral inactivation market size, by product & service, 2018-2030 (US$M)

UK Viral Inactivation Market Outlook Share, 2024 & 2030 (US$M)

UK viral inactivation market size, by product & service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online